Table 3.
Outcomes | All Patients, n=112 | Minimal or Negative Hematuria during Follow-Up, n=66 | Persistent Hematuria during Follow-Up, n=46 | P Value |
---|---|---|---|---|
ESRD, no. (%) | 21 (17.2) | 7 (10.6) | 14 (30.4) | 0.01 |
50% Reduction in renal function, no. (%) | 27 (22.1) | 10 (15.2) | 17 (37) | 0.01 |
Rate of renal function decline, ml/min per 1.73 m2 per yr | −2.34±5 | −1.54±3.92 | −3.34±6.12 | 0.06 |